eLetters

61 e-Letters

published between 2007 and 2010

  • Government decision on national human papillomavirus vaccine programme is a sad day for sexual healt
    Christopher Sonnex

    Dear Editor,

    The points made by Dr O’Mahony in response to the government’s decision to support a bivalent HPV 16/18 prophylactic vaccine in preference to a quadrivalent HPV 6/11/16/18 vaccine are well made and will be appreciated by practitioners managing the wide spectrum of ano-genital HPV disease.1 The British Association for Sexual Health and HIV (BASHH) has already expressed concerns with respect to the clinica...

    Show More
  • Re: HPV immunization programme: not shocked or appalled
    Colm O'Mahony

    Dear Editor,

    I note Dr Watson wishes to "reserve his judgement" about the Cervarix versus Gardasil decision until he knows the details. Unfortunately he will be reserving his judgment ad infinitum because despite requests from me and others the Department of Health refused to release the details of the decision. They have issued the criteria and it appears to have been a tick boxing exercise where cost was paramoun...

    Show More
  • HPV immunization programme: not shocked or appalled
    Peter G Watson

    Dear Editor,

    I wish to distance myself from Colm O'Mahony's rather hysterical editorial on the selection of Cervarix for the human papillomavirus immunization programme (O'Mahony C. Government decision on national human papillomavirus vaccine (HPV) programme is a sad day for sexual health. Sex Transm Infect 2008;84:251). I do not yet know why Cervarix was selected ahead of Gardasil and until I do I wish to reserve my...

    Show More
  • Circumcised MSM in the UK no less likely to be living with HIV
    Ford CI Hickson

    Dear Editor,

    If MacDonald, Humphreys and Jaffe (2008, STI, 84) are correct in their contention that circumcising men who have sex with men will result in a reduction in HIV incidence among this population, then we would expect circumcised MSM in the UK have a lower incidence of HIV than un-circumcised MSM. This should be reflected in HIV prevalence and since there is no reason to think that circumcision promotes diag...

    Show More
  • ELECTRONIC PATIENT RECORDS IN A SEXUAL HEALTH SERVICE
    BENJAMIN P GOORNEY

    Dear Editor,

    The recent article published in this journal(1) emphasised the importance of effective planning and implementation for the success of EPR. In 2006 as part of a city wide “collaborative integration “ between sexual health service providers in Salford,we transferred to a “shared electronic record” between Genitourinary medicine(GUM), Family planning(F.P.) and young persons(Y.P.) services as part of a...

    Show More
  • Prevalence of Neisseria gonorrhoea infection in young women in South London
    Adamma R. Aghaizu

    Dear Editor,

    Gopal Rao et al. found a high prevalence of gonorrhoea infection (3.8%) in women aged...

    Show More
  • Timing of chlamydia tests
    Carolyn E Rigg

    Dear Editor,

    In the editorial Focus on chlamydia(1), screening of asymptomatic individuals to prevent transmission and adverse consequences of chlamydia was discussed. We wish to raise the issue of uncertainty around the appropriate timing of chlamydia tests in relation to exposure.

    The National Chlamydia Screening Programme (NCSP) Core Requirements (3rd Edition) states ‘There is no data on the use of nucle...

    Show More
  • Assessing anal intercourse and blood exposures as routes of HIV transmission in Mombasa, Kenya
    John J Potterat

    Dear Editor,

    The report by Grijsen and colleagues documenting the high frequency of unprotected receptive anal intercourse (RAI) in young Kenyans at high risk for HIV infection (1) is a welcome contribution to the small but growing number of studies investigating RAI as a specific risk for HIV in sub-Saharan Africa (2-7). Their study, however, presents us with yet another anomaly unlikely to be resolved by the assessme...

    Show More
  • Don't tell, don't ask?
    Elizabeth Pisani

    Dear Editor,

    I was pleased that the authors suggested that missed opportunities for early diagnosis could be reduced by tackling the problem from both the patient and the provider side. They note:

    "From a patient perspective, the likelihood of future diagnosis could be improved by encouraging at-risk groups (for example, MSM) to access health care when they experience symptoms of seroconversion or followi...
    Show More
  • The KC60 and the future
    John G Evans-Jones

    Dear Editor,

    What will become of the KC60? In the October 2007 edition of this journal. Hughes et al (1) reported on the KC60 returns from genitourinary medicine (GUM) clinics for 2006. They comment in their conclusion that diagnoses made outside GUM are not included, which is clearly a major deficiency if we are using the KC60 as an epidemiological surveillance tool.

    Some community data does find a way in....

    Show More

Pages